sk&f 86002 has been researched along with Allergic Encephalomyelitis in 1 studies
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole: inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiMartino, MJ | 1 |
| Wolff, CE | 1 |
| Campbell, GK | 1 |
| Hanna, N | 1 |
1 other study available for sk&f 86002 and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Inhibition of experimental allergic encephalomyelitis by a new anti-inflammatory compound--SK&F 86002.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Encephalomyelitis, Autoimmune, Experimental; Imida | 1988 |